JCB logo
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1083/jcb.200904125
The Journal of Cell Biology, Vol. 185, No. 5, 761-763
The Rockefeller University Press, 0021-9525 $30.00
© Horsley
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF, 1334K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Horsley, V.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horsley, V.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Stem Cells
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Comment

Epigenetics, Wnt signaling, and stem cells: the Pygo2 connection



Valerie Horsley

Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06522

Correspondence to Valerie Horsley: valerie.horsley{at}yale.edu

Stem cells use both transcriptional and epigenetic mechanisms to control gene expression and regulate tissue development and homeostasis. In this issue, Gu et al. (Gu, B., P. Sun, Y. Yuan, R.C. Moraes, A. Li, A. Teng, A. Agrawal, C. Rhéaume, V. Bilanchone, J.M. Veltmaat, et al. 2009. J. Cell Biol. 185:811–826) reveal an important link between these two mechanisms in mammary epithelial stem cells by showing that transcriptional activation of β-catenin downstream of Wnt signaling can be regulated epigenetically through a chromatin remodeling factor, Pygo2.


© 2009 Horsley
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jcb.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).

The recent characterization of stem cells in mammary epithelium has opened the door for understanding how mammary epithelial stem cells are regulated during tissue development, homeostasis, and tumorigenesis (Shackleton et al., 2006; Stingl et al., 2006). Fully functional mammary gland formation occurs in three stages: embryonic development, puberty, and pregnancy. During embryogenesis, cells of the multipotent ventral ectoderm condense to form placodes that migrate into the dense mammary mesenchyme to form a rudimentary ductal tree. In response to hormonal changes during puberty, the ductal tree matures into a complex, branched network of growing ducts that terminate into terminal end buds (TEBs), each containing stem cells with the capacity to form either ductal or luminal alveolar cell types. Pregnancy activates rapid growth and proliferation of TEB stem cell populations to form expansive ductal networks and to differentiate into secretory alveoli, which produce milk that is secreted into the ductal lumens during lactation. At the end of lactation, ductal and alveoli structures regress, and stem cells of the TEB await another round of growth and differentiation during subsequent pregnancies. It is thought that stem cells in the mammary epithelium are involved in tumor development (Molyneux et al., 2007).

Multiple stages of mammary development and tumorigenesis are regulated by Wnt/β-catenin signaling (Boras-Granic and Wysolmerski, 2008). Wnt ligands signal by increasing cytoplasmic pools of β-catenin. In unstimulated cells, β-catenin is phosphorylated and targeted to ubiquitin-mediated degradation through its interaction with the multiprotein axin complex containing adenomatous polyposis coli protein and GSK3β. When secreted Wnt proteins bind to Frizzled receptors, formation of the axin complex is inhibited, leading to cytoplasmic accumulation and nuclear translocation of β-catenin. In coordination with Tcf (T cell factor)/lymphoid enhancer factor (Lef) DNA–binding proteins, β-catenin regulates the transcription of several gene targets and is crucial for mammary development. Deletion of Lef1 (van Genderen et al., 1994) or overexpression of Dkk1, a soluble inhibitor of Wnt ligands, halts mammary gland development (Andl et al., 2002; Chu et al., 2004). In addition, Wnts can promote tumorigenesis in mammary epithelium (Nusse and Varmus, 1982) and can increase mammary stem cell number four- to sixfold (Shackleton et al., 2006).

Pygopus (Pygo) genes were first identified in Drosophila melanogaster as one mechanism that controls Wnt/β-catenin signaling. In Drosophila, Pygo proteins control β-catenin–Lef–Tcf transcriptional complexes through regulation of either β-catenin nuclear translocation or by binding to β-catenin via the adapter protein BCL9 (Belenkaya et al., 2002; Kramps et al., 2002; Parker et al., 2002; Thompson, 2004). Pygo proteins also contain a plant homeo domain (PHD; Fiedler et al., 2008) that binds to methylated residues on lysine 4 of histone H3 (H3K4me), an epigenetic mark linked to active transcription (Santos-Rosa et al., 2002). However, the biological relevance of Pygo’s binding to methylated histone residues or how these interactions function to regulate Wnt signaling was unclear.

Now, Gu et al. (see p. 811 of this issue) make the first link between Pygo expression and regulation of Wnt signaling in a mammalian tissue. Two pygo genes exist in mammals, mPygo1 and mPygo2, with the latter having a broader expression pattern (Li et al., 2004). Examination of the phenotype of Pygo2 deletion in mammary epithelium revealed reduced formation of mammary placodes during embryogenesis caused by decreased progenitor proliferation. In epithelial-specific Pygo2-null mice, postnatal mammary development that does progress to form ductal networks exhibits reduced ductal elongation and a lack of TEB structures (Fig. 1). Analysis of the number and function of mammary stem cells (LinCD24+/CD29High) in these mutant ductal structures revealed reductions in both stem cell number and the ability to form mammary structures in transplantation assays, thus confirming a role for Pygo2 in mammary stem cell self-renewal. Furthermore, Wnt signaling is reduced in Pygo2-null mammary epithelium. Thus, Pygo2 controls proliferation and self-renewal of embryonic mammary epithelial progenitors and postnatal stem cells through the promotion of Wnt signaling (Fig. 1).


Figure 1
View larger version (94K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1. Pygo2 regulates Wnt signaling during mammary gland development. Pygo2 promotes trimethylation (yellow) of lysine 4 of histone H3 (H3K4) and synergistically binds these residues and BCL9–β-catenin complexes to activate β-catenin target genes in mammary epithelium. Loss of Pygo2 in mice results in embryonic defects of mammary progenitor cells and placode (white circle) formation. In addition, loss of Pygo2 results in postnatal defects in mammary ductal networks caused by the lack of stem cells in TEBs (purple circles). Pygo2-null mammary glands rescue mammary overgrowth phenotypes when Wnt signaling is hyperactivated.

 
How does Pygo2 regulate Wnt signaling and progenitor proliferation in the mammary gland? Using biochemistry, cell biology, and mouse genetics, Gu et al. (2009) demonstrate that Pygo2 promotes Wnt signaling in mammary epithelium through its synergistic interactions with di- and trimethylated histones and the recruitment of β-catenin–BCL9 complexes to promoters of β-catenin target genes. Pygo2 expression in mammary epithelium is required for Lef1 expression and Wnt signaling reporter activation similar to its role in Drosophila and Xenopus laevis. Furthermore, loss of Pygo2 can suppress overgrowth in mammary glands expressing activating mutations of β-catenin (Fig. 1). The regulation of mammary cell proliferation requires Pygo2’s ability to interact with trimethylated K4 residues of histone H3 and its interaction with BCL9–β-catenin complexes at β-catenin target genes. Together, these data support the key role of Pygo2 as a link between activated chromatin and the recruitment of β-catenin to its target genes.

The regulation of developmental processes by proteins that bind to and activate H3 K4 methylation has been described for other PHD-containing proteins, including WDR5. Interestingly, WDR5 also regulates Xenopus development and murine osteoblast formation (Wysocka et al., 2005; Gori et al., 2006) and can have specificity by regulating Wnt signaling (Zhu et al., 2008). Additional chromatin regulators have been shown to link epigenetic and transcriptional control of gene expression, as shown for MLL1 at Hox genes (Guenther et al., 2005). However, the regulatory mechanisms that link these epigenetic regulatory factors to transcription are not clear. Future insights into how proteins that recognize activating or repressive epigenetic histone marks through their recruitment of specific transcription factors will further extend our knowledge of the important link between epigenetic and transcriptional regulation of gene expression.

Beyond its function in regulating gene expression, Pygo’s role in the proliferation of mammary progenitors reveals several interesting aspects of mammary biology. First, common mechanisms that regulate embryonic mammary progenitors and adult mammary stem cells have not been identified. The data presented by Gu et al. (2009) suggest that Pygo2 regulates proliferation of both embryonic mammary progenitors and postnatal mammary stem cells of the TEB, revealing the first mechanism of shared regulation by these pools of mammary progenitor populations. Furthermore, the control of proliferation by Pygo2 suggests that blocking Pygo2 may serve as a potential therapeutic target given its striking ability to block mammary overgrowth with Wnt hyperactivation (Fig. 1). Future studies identifying molecules or proteins that regulate the activity or the interactions of Pygo2 may serve as potent mammary tumor inhibitors.


Acknowledgments
I thank Drs. Weimin Zhong and Matthew Rodeheffer for comments on this manuscript.

The Horsley laboratory is funded by grants from the National Institutes of Health (4R00AR054775) and the Connecticut Department of Public Health (09SCAYALE30).

Submitted: 23 April 2009

Accepted: 4 May 2009


References

Andl, T., S. Reddy, T. Gaddapara, and S. Millar. 2002. WNT signals are required for the initiation of hair follicle development. Dev. Cell. 2:643–653.[CrossRef][Medline]

Belenkaya, T.Y., C. Han, H.J. Standley, X. Lin, D.W. Houston, and J. Heasman. 2002. pygopus Encodes a nuclear protein essential for wingless/Wnt signaling. Development. 129:4089–4101.[Abstract/Free Full Text]

Boras-Granic, K., and J.J. Wysolmerski. 2008. Wnt signaling in breast organogenesis. Organogenesis. 4:116–122.[Medline]

Chu, E.Y., J. Hens, T. Andl, A. Kairo, T.P. Yamaguchi, C. Brisken, A. Glick, J.J. Wysolmerski, and S.E. Millar. 2004. Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis. Development. 131:4819–4829.[Abstract/Free Full Text]

Fiedler, M., M.J. Sanchez-Barrena, M. Nekrasov, J. Mieszczanek, V. Rybin, J. Muller, P. Evans, and M. Bienz. 2008. Decoding of methylated histone H3 tail by the Pygo-BCL9 Wnt signaling complex. Mol. Cell. 30:507–518.[CrossRef][Medline]

Gori, F., L.G. Friedman, and M.B. Demay. 2006. Wdr5, a WD-40 protein, regulates osteoblast differentiation during embryonic bone development. Dev. Biol. 295:498–506.[CrossRef][Medline]

Gu, B., P. Sun, Y. Yuan, R.C. Moraes, A. Li, A. Teng, A. Agrawal, C. Rhéaume, V. Bilanchone, J.M. Veltmaat, et al. 2009. Pygo2 expands mammary progenitor cells by facilitating histone H3 K4 methylation. J. Cell Biol. 185:811–826.[Abstract/Free Full Text]

Guenther, M.G., R.G. Jenner, B. Chevalier, T. Nakamura, C.M. Croce, E. Canaani, and R.A. Young. 2005. Global and Hox-specific roles for the MLL1 methyltransferase. Proc. Natl. Acad. Sci. USA. 102:8603–8608.[Abstract/Free Full Text]

Kramps, T., O. Peter, E. Brunner, D. Nellen, B. Froesch, S. Chatterjee, M. Murone, S. Züllig, and K. Basler. 2002. Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex. Cell. 109:47–60.[CrossRef][Medline]

Li, B., D. Mackay, J. Ma, and X. Dai. 2004. Cloning and developmental expression of mouse pygopus 2, a putative Wnt signaling component. Genomics. 84:398–405.[CrossRef][Medline]

Molyneux, G., J. Regan, and M.J. Smalley. 2007. Mammary stem cells and breast cancer. Cell. Mol. Life Sci. 64:3248–3260.[CrossRef][Medline]

Nusse, R., and H. Varmus. 1982. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell. 31:99–109.[CrossRef][Medline]

Parker, D.S., J. Jemison, and K.M. Cadigan. 2002. Pygopus, a nuclear PHD-finger protein required for Wingless signaling in Drosophila. Development. 129:2565–2576.[Abstract/Free Full Text]

Santos-Rosa, H., R. Schneider, A.J. Bannister, J. Sherriff, B.E. Bernstein, N.C. Emre, S.L. Schreiber, J. Mellor, and T. Kouzarides. 2002. Active genes are tri-methylated at K4 of histone H3. Nature. 419:407–411.[CrossRef][Medline]

Shackleton, M., F. Vaillant, K.J. Simpson, J. Stingl, G.K. Smyth, M.L. Asselin-Labat, L. Wu, G.J. Lindeman, and J.E. Visvader. 2006. Generation of a functional mammary gland from a single stem cell. Nature. 439:84–88.[CrossRef][Medline]

Stingl, J., P. Eirew, I. Ricketson, M. Shackleton, F. Vaillant, D. Choi, H.I. Li, and C.J. Eaves. 2006. Purification and unique properties of mammary epithelial stem cells. Nature. 439:993–997.[Medline]

Thompson, B.J. 2004. A complex of Armadillo, Legless, and Pygopus coactivates dTCF to activate wingless target genes. Curr. Biol. 14:458–466.[CrossRef][Medline]

van Genderen, C., R. Okamura, I. Fariñas, R. Quo, T. Parslow, L. Bruhn, and R. Grosschedl. 1994. Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice. Genes Dev. 8:2691–2703.[Abstract/Free Full Text]

Wysocka, J., T. Swigut, T.A. Milne, Y. Dou, X. Zhang, A.L. Burlingame, R.G. Roeder, A.H. Brivanlou, and C.D. Allis. 2005. WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development. Cell. 121:859–872.[CrossRef][Medline]

Zhu, E.D., M.B. Demay, and F. Gori. 2008. Wdr5 is essential for osteoblast differentiation. J. Biol. Chem. 283:7361–7367.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

Pygo2 expands mammary progenitor cells by facilitating histone H3 K4 methylation
Bingnan Gu, Peng Sun, Yuanyang Yuan, Ricardo C. Moraes, Aihua Li, Andy Teng, Anshu Agrawal, Catherine Rhéaume, Virginia Bilanchone, Jacqueline M. Veltmaat, Ken-Ichi Takemaru, Sarah Millar, Eva Y.-H.P. Lee, Michael T. Lewis, Boan Li, and Xing Dai
J. Cell Biol. 2009 185: 811-826. [Abstract] [Full Text] [PDF]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF, 1334K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Horsley, V.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horsley, V.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Stem Cells
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents